Placebo control group in COVID-19 vaccine trials: context and timing matters.

Dal-Ré, Rafael

Dal-Ré, Rafael.

Dal-Ré R; Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain. rafael.dalre@quironsalud.es.

Eur J Clin Pharmacol ; 78(3): 523-526, 2022 Mar.

Article in English | MEDLINE | ID: covidwho-1536293

Subject(s)

COVID-19 Vaccines/therapeutic use; Placebos; Research Design; COVID-19; Control Groups; Humans; Randomized Controlled Trials as Topic

Keywords

COVID-19; Emergency use authorization Low- and middle-income countries; Ethics; Placebo-controlled trials; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Placebos / Research Design / COVID-19 Vaccines Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Eur J Clin Pharmacol Year: 2022 Document Type: Article Affiliation country: S00228-021-03259-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google